Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Research Article

  • 25,472 Articles
  • 0 Posts
  • ← Previous
  • 1
  • 2
  • …
  • 2393
  • 2394
  • 2395
  • …
  • 2547
  • 2548
  • Next →
GALACTOSE DISAPPEARANCE FROM THE BLOOD STREAM. CALCULATION OF A GALACTOSE REMOVAL CONSTANT AND ITS APPLICATION AS A TEST FOR LIVER FUNCTION
Henry Colcher, … , Arthur J. Patek Jr., Forrest E. Kendall
Henry Colcher, … , Arthur J. Patek Jr., Forrest E. Kendall
Published September 1, 1946
Citation Information: J Clin Invest. 1946;25(5):768-775. https://doi.org/10.1172/JCI101761.
View: Text | PDF

GALACTOSE DISAPPEARANCE FROM THE BLOOD STREAM. CALCULATION OF A GALACTOSE REMOVAL CONSTANT AND ITS APPLICATION AS A TEST FOR LIVER FUNCTION

  • Text
  • PDF
Abstract

Authors

Henry Colcher, Arthur J. Patek Jr., Forrest E. Kendall

×

DETERMINATION OF THE RATE OF DISAPPEARANCE OF MUSTARD GAS AND MUSTARD INTERMEDIATES IN CORNEAL TISSUE
V. Everett Kinsey, W. Morton Grant
V. Everett Kinsey, W. Morton Grant
Published September 1, 1946
Citation Information: J Clin Invest. 1946;25(5):776-779. https://doi.org/10.1172/JCI101762.
View: Text | PDF

DETERMINATION OF THE RATE OF DISAPPEARANCE OF MUSTARD GAS AND MUSTARD INTERMEDIATES IN CORNEAL TISSUE

  • Text
  • PDF
Abstract

Authors

V. Everett Kinsey, W. Morton Grant

×

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). I. THE SYSTEMIC TREATMENT OF EXPERIMENTAL ARSENIC POISONING (MAPHARSEN, LEWISITE, PHENYL ARSENOXIDE) WITH BAL
Harry Eagle, … , Harold J. Magnuson, Ralph Fleischman
Harry Eagle, … , Harold J. Magnuson, Ralph Fleischman
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):451-466. https://doi.org/10.1172/JCI101728.
View: Text | PDF

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). I. THE SYSTEMIC TREATMENT OF EXPERIMENTAL ARSENIC POISONING (MAPHARSEN, LEWISITE, PHENYL ARSENOXIDE) WITH BAL

  • Text
  • PDF
Abstract

Authors

Harry Eagle, Harold J. Magnuson, Ralph Fleischman

×

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE
J. Wexler, … , H. J. Magnuson, E. B. Watson
J. Wexler, … , H. J. Magnuson, E. B. Watson
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):467-473. https://doi.org/10.1172/JCI101729.
View: Text | PDF

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). II. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN NORMAL SUBJECTS AND AFTER MINIMAL EXPOSURE TO ARSENICAL SMOKE

  • Text
  • PDF
Abstract

Authors

J. Wexler, H. Eagle, H. J. Tatum, H. J. Magnuson, E. B. Watson

×

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION
Marion B. Sulzberger, … , Rudolf L. Baer, Abram Kanof
Marion B. Sulzberger, … , Rudolf L. Baer, Abram Kanof
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):474-479. https://doi.org/10.1172/JCI101730.
View: Text | PDF

CLINICAL USES OF 2,3—DIMERCAPTOPROPANOL (BAL). III. STUDIES ON THE TOXICITY OF BAL ON PERCUTANEOUS AND PARENTERAL ADMINISTRATION

  • Text
  • PDF
Abstract

Authors

Marion B. Sulzberger, Rudolf L. Baer, Abram Kanof

×

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN
Walter Modell, … , Harry Gold, McKeen Cattell
Walter Modell, … , Harry Gold, McKeen Cattell
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):480-487. https://doi.org/10.1172/JCI101731.
View: Text | PDF

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). IV. PHARMACOLOGIC OBSERVATIONS ON BAL BY INTRAMUSCULAR INJECTION IN MAN

  • Text
  • PDF
Abstract

Authors

Walter Modell, Harry Gold, McKeen Cattell

×

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL
Marion B. Sulzberger, … , Rudolf L. Baer, Abram Kanof
Marion B. Sulzberger, … , Rudolf L. Baer, Abram Kanof
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):488-496. https://doi.org/10.1172/JCI101732.
View: Text | PDF

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). V. SKIN SENSITIZATION TO BAL

  • Text
  • PDF
Abstract

Authors

Marion B. Sulzberger, Rudolf L. Baer, Abram Kanof

×

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VI. THE TREATMENT OF COMPLICATIONS OF ARSENO-THERAPY WITH BAL (BRITISH ANTI-LEWISITE)
A. B. Carleton, … , G. A. Levvy, A. C. Chance
A. B. Carleton, … , G. A. Levvy, A. C. Chance
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):497-527. https://doi.org/10.1172/JCI101733.
View: Text | PDF

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VI. THE TREATMENT OF COMPLICATIONS OF ARSENO-THERAPY WITH BAL (BRITISH ANTI-LEWISITE)

  • Text
  • PDF
Abstract

Authors

A. B. Carleton, R. A. Peters, L. A. Stocken, R. H. S. Thompson, D. I. Williams, I. D. E. Storey, G. A. Levvy, A. C. Chance

×

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL
W. T. Longcope, … , M. M. Wintrobe, Val Jäger
W. T. Longcope, … , M. M. Wintrobe, Val Jäger
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):528-533. https://doi.org/10.1172/JCI101734.
View: Text | PDF

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VII. THE TREATMENT OF ARSENICAL DERMATITIS WITH PREPARATIONS OF BAL

  • Text
  • PDF
Abstract

Authors

W. T. Longcope, John A. Luetscher Jr., M. M. Wintrobe, Val Jäger

×

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION
John A. Luetscher Jr., … , Warfield T. Longcope, Emily B. Watson
John A. Luetscher Jr., … , Warfield T. Longcope, Emily B. Watson
Published July 1, 1946
Citation Information: J Clin Invest. 1946;25(4):534-540. https://doi.org/10.1172/JCI101735.
View: Text | PDF

CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION

  • Text
  • PDF
Abstract

Authors

John A. Luetscher Jr., Harry Eagle, Warfield T. Longcope, Emily B. Watson

×
  • ← Previous
  • 1
  • 2
  • …
  • 2393
  • 2394
  • 2395
  • …
  • 2547
  • 2548
  • Next →

No posts were found with this tag.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts